UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047364
Receipt number R000054022
Scientific Title The effect of glaucoma eye drops on the anterior chamber in cataract patients
Date of disclosure of the study information 2022/05/01
Last modified on 2022/06/29 21:03:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of glaucoma eye drops on the anterior chamber in cataract patients

Acronym

The effect of glaucoma eye drops on the anterior chamber in cataract patients

Scientific Title

The effect of glaucoma eye drops on the anterior chamber in cataract patients

Scientific Title:Acronym

The effect of glaucoma eye drops on the anterior chamber in cataract patients

Region

Japan


Condition

Condition

cataracts with glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To reveal the effect of glaucoma eye drops on the anterior chamber in cataract patients

Basic objectives2

Others

Basic objectives -Others

To evaluate whether the effect of glaucoma eye drops on the anterior chamber in cataract patients change depending on the kinds of them.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cytokines and proteins in anterior chamber

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who receive cataracts surgeries

Key exclusion criteria

uveitis

Target sample size

160


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Kaneko

Organization

Nagoya University

Division name

Department of Ophthalmology

Zip code

466-8550

Address

65 Tsurumai, Showa-ku, Nagoya

TEL

0527442275

Email

h-kaneko@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Kaneko

Organization

Nagoya University

Division name

Department of Ophthalmology

Zip code

466-8550

Address

65 Tsurumai, Showa-ku, Nagoya

TEL

052-744-2277

Homepage URL


Email

h-kaneko@med.nagoya-u.ac.jp


Sponsor or person

Institute

Department of Ophthalmology, Nagoya University

Institute

Department

Personal name



Funding Source

Organization

Department of Ophthalmology, Nagoya University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Ophthalmology, Nagoya University

Address

65 Tsurumai-cho, Showa-ku, Nagoya

Tel

052-744-2277

Email

h-kaneko@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学医学部附属病院(愛知県)、医療法人湘山会眼科三宅病院(愛知県)、桜眼科クリニック(愛知県)


Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 03 Month 17 Day

Date of IRB

2022 Year 04 Month 19 Day

Anticipated trial start date

2022 Year 05 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2022 Year 04 Month 01 Day

Last modified on

2022 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054022


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name